| INTRODUC TI ON
Endometriosis, a benign disease, is defined as the presence of endometrial tissue outside the uterine cavity. 1 The estimated prevalence of the condition ranges from 2% to 10%. 2 Rates of endometriosis in the range of 35%-50% are seen in women suffering from pelvic pain or infertility or both. 3 The main symptoms of endometriosis are dysmenorrhea, pelvic pain, and infertility. 4 The severity of the pain reported shows a wide range, but without any relation to the morphological stage of the endometriosis. 5 The women affected also
show an increase in uterine contractility, and uterine hyperperistalsis and dysperistalsis are typically noted. 6 The treatment consists of either surgical removal of endometriotic lesions, or medical treatment using gonadotropin-releasing hormone (GnRH) analogs, progestins, or combined oral contraceptive pills. 2, 7 The synthetic progestin dienogest (17α-17-hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile) was initially used as one of the components in combined hormonal contraceptives. It has been approved since 2010 for the treatment of endometriosis, at a daily dosage of 2 mg. 8 Studies have already demonstrated that it leads to a reduction in pain similar to that provided by GnRH analogs in patients suffering from endometriosis, along with a significantly better sideeffect profile. [8] [9] [10] Dienogest is therefore the treatment of first choice and is preferable to GnRH analogs. 2, 7 In 1986, Bulletti et al reported the first experiments with extracorporeally perfused human uteri. Physiological conditions can be maintained for up to 7 hours, as has previously been shown.
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The purpose of the present study was to investigate the effects of dienogest on uterine contractions, using progesterone as the reference substance.
| MATERIAL AND ME THODS

| Swine uterus
Swine uteri are often used in research, as they have a number of anatomical and physiological characteristics in common with human uteri. The swine uterus is a bicornuate uterus with a single body about 5 cm long and a single cervix about 15 cm long. 17, 18 The histological structure of the swine uterus is similar to that of the human uterus. The three elements of the uterine wall are, from inside to outside: endometrium, myometrium, and perimetrium.
The myometrium consists of smooth muscle cells oriented in an inner circular layer and an outer longitudinal layer, and it induces the contractions measured in the experiment. 17, 18 The sow is polyestrous, normally with an estrous cycle of about 20-21 days. This cycle is separated into four stages: estrus, metestrus, diestrus, and proestrus.
All of the swine uteri were supplied from healthy animals on a daily basis from the local slaughterhouse. After the sow has been killed by electric shock, the uterus is separated from the rest of the body within about 2 minutes. The mean weight of the uteri was 122.8 g (range 71.6-159.2 g). The overall condition of the uteri, the condition of the uterine arteries, and the weight of the organ were the most important criteria used to select the uteri. It was not known in which part of the estrus cycle the animals were, and this was therefore not a selection criterion.
| Perfusion system
After dissection, both uterine arteries were canalized with 24-G needles (Introcan Certo; B. Braun Melsungen AG, Melsungen, Germany) and afterwards the uterus was placed in a temperaturecontrolled perfusion chamber (Karl Lettenbauer, Erlangen, Germany) filled with perfusion medium (Figure 1 ). For the first few minutes, each artery was also connected to a reservoir containing the perfusion medium. The perfusion medium used was a modified
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Progesterone is administered in conservative treatment for endometriosis and reduces uterine contractility.
Perfusion of the uterus with dienogest (a synthetic gestagen) in an extracorporeal swine perfusion model led to a reduced uterus contractility, comparable to the known progesterone effect.
F I G U R E 1 A swine uterus with arterial catheters placed in the uterine artery [Color figure can be viewed at wileyonlinelibrary. com]
Krebs-Ringer bicarbonate solution containing NaCl 6.896 g/L, KCl
and insulin 50 IU/L. The pH was checked and adjusted to 7.4.
The modified Krebs-Ringer bicarbonate solution was then continued, for the control group; or the swine uteri were perfused with the medium containing progesterone at concentrations of 10, 20, or 40 ng/mL; or dienogest at concentrations of 10, 20, 40, or 80 ng/mL. Throughout the experiment, the perfusion medium was constantly oxygenated with carbogen gas, a mixture of 95% oxygen and 5% carbon dioxide (Linde AG, Pullach, Germany), the temperature of the medium was constantly 37°C with a continuous perfusion rate of 10-15 mL/min, depending on the intraarterial pressure; mean intraarterial pressure was 60-80 mm Hg. A heparin perfusion is normally not necessary to prevent vascular obstruction.
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| Vitality parameters
Vitality parameters were analyzed using a Radiometer ABL800Flex
analyzer (Radiometer Ltd., Willich, Germany). Perfusate samples were taken at 1-or 2-hour intervals, with the following data being measured: pH (Figure 2 ), po 2 , pco 2 , lactate, and HCO 3 , data not shown but were reported previously in detail.
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| Intrauterine pressure measurement
Uterine contractions were measured using a double-chip microcatheter (Urobar DLS-SF; Raumedic AG, Dietzenbach, Germany) placed in an intrauterine location with a distance of 7 cm between the two intracavity pressure (ICP) sensors. The first pressure sensor was placed in the upper body of the uterus, near the fundus (ICP 1), and the other in the lower body, near the isthmus (ICP 2). After calibration of the system to atmospheric pressure, the experiment was started.
The double-chip microcatheter was connected to a Datalogger (MPR 1; Raumedic) and the data for uterine contractions, measured in real time, were transferred to a personal computer. 
| Induction of uterine contractions
| Drugs
The effects of progesterone and dienogest on uterine contractions were investigated. Initially, the two agents were dissolved in 
| Statistical analysis
The Wilcoxon signed-rank test was used to evaluate significant differences. Statistical significance was set at P < .05.
| RE SULTS
A total of 90 uteri were perfused either with progesterone solution, dienogest solution, or with only the Krebs-Ringer bicarbonate solution in the control group. Eight uteri could not be analyzed due to methodological problems during perfusion. Those uteri showed no contractions at all or the vitality parameters were out of the range right at the beginning of the perfusion experiment. The number of all perfused uteri is shown in Table 1 .
The uteri were perfused for at least 4 hours. During this period, the vitality parameters remained almost within the physiological range ( Figure 2 ). The amplitude and frequency of uterine contractions and the area under the curve (AUC) were analyzed.
| Progesterone
Each concentration of progesterone resulted in a decrease in the amplitude of uterine contractions at both measurement sites (ICP 1 near the fundus, ICP 2 near the isthmus) ( Figure 3 ). In comparison with the control group, the decrease near the isthmus (ICP 2) was In addition to the amplitude of uterine contractions, the AUC also
showed a decrease at all of the concentrations measured ( Figure 5 ).
A significant decrease (P < 0.05) in the AUC near the isthmus was detected at all of the concentrations perfused. Near the fundus, only the concentration of 40 ng/mL progesterone showed a significant decrease (P < 0.05).
| Dienogest
Significant decreases in the amplitude of uterine contractions were measured near the isthmus after perfusion with dienogest 20 ng/mL (P < 0.01), 40 ng/mL (P < 0.01), and 80 ng/mL (P < 0.05), but the decrease did not reach significant levels near the fundus A significant decrease in the AUC was observed near the isthmus at dienogest concentrations of 20 ng/mL (P < 0.01), 40 ng/ mL (P < 0.01), and 80 ng/mL (P < 0.05) ( Figure 5 ). No significant differences were detected near the fundus, but a trend toward a concentration-dependent decrease was noted.
| Comparison of progesterone and dienogest
Decreases in the amplitude of contractions and decreases in the AUC were observed at all of the measured concentrations for both test substances, reflecting an inhibitory effect of both substances on uterine contractility. However, progesterone caused a significant decrease at all of the measurement sites, whereas dienogest caused a significant decrease only at the isthmus, and the changes at the fundus did not reach significance. The frequency of uterine contractions was not influenced by either progesterone or dienogest.
| D ISCUSS I ON
Women suffering from endometriosis have a wide range of symptoms, such as dysmenorrhea, pelvic pain, and infertility, but 20%-25% of them also remain asymptomatic. 19, 20 Endometriosis is a condition associated with a high morbidity rate, which affects women's physical and also psychological well-being.
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Various theories to explain endometriosis have been suggested.
In the earliest of these, in 1927, Sampson proposed that endometrial lesions might develop in the peritoneum as a result of retrograde menstruation. 21 However, the exact cause of endometriosis still remains unclear. More recently, Leyendecker et al have suggested that uterine microtrauma causes higher levels of local estrogen production, which may cause uterine hyperperistalsis, as a result of which some cells in the basal endometrium are replaced. 4, 22 In recent years, the focus has more and more been on a correlation between disturbed uterine contractility and the occurrence of there is an increase in uterine contractions directed from the cervix toward the fundus, supporting sperm transport. This is followed by the luteal phase, in which, under the influence of progesterone, fewer uterine contractions occur and the uterus passes into a relatively inactive phase, supporting implantation. 6, [24] [25] [26] [27] A typical finding in endometriosis is uterine hyperperistalsis and dysperistalsis. 6, 19, 24, 28 In addition to surgical removal of endometriosis lesions, there is also the option of medical treatment using GnRH analogs or synthetic progestogens such as dienogest. Due to its chemical structure, dienogest has a special pharmacological profile. It combines the characteristics of C-19 nortestosterone and progesterone derivatives. 29 Dienogest has an affinity for the progesterone receptor that is approximately 10% that of progesterone. 30 By inhibiting the synthesis of estradiol, dienogest leads to atrophy of endometrial lesions. 30 Cosson et al have shown that postoperative treatment with dienogest is as effective as treatment with GnRH analogs. 9 Various studies have also reported that dienogest reduces pain. 8, 10 One mechanism for the effect of dienogest may be its influence on uterine contractility, with a reduction in hyperperistalsis and dysperistalsis, and hence a reduction in uterine pressure.
The extracorporeal perfusion model of swine uteri was used in the present study to investigate the influence of dienogest, with progesterone as the reference substance. This perfusion model has been used by our research group for many years and allows investigations to be carried out in physiological conditions.
The study again confirms the known inhibitory effect of progesterone in this ex vivo model, as reported previously. 
| CON CLUS ION
The inhibitory effect of dienogest on the contractility of the uterus was found to be similar to that of progesterone in this study. This study also once again shows that the extracorporeal perfusion model of swine uteri that has been employed by our research group for many years can be used to investigate the effects of different substances on uterine activity in physiological conditions.
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